Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (231-240 of 311) with videos related to

Pageof 32
Sort By:
Oncotarget|December 2, 2016
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancerMarzia A Locatelli, Philippe Aftimos, E Claire Dees, et al.
Clinical Colorectal Cancer|July 8, 2020
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast CancerSilvia Camera, Amélie Deleporte, Giacomo Bregni, et al.
Anticancer Research|June 10, 2019
Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted TherapiesZiad El Ali, Sylvie Rottey, Philippe Barthelemy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2022
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket studyFederico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, et al.
Future Oncology (London, England)|May 9, 2025
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to accessJesús Garcia-Foncillas, Arnaud Bayle, Dirk Arnold, et al.
Journal of Cancer Research and Clinical Oncology|July 22, 2022
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysisDiogo Martins-Branco, Guilherme Nader-Marta, Ana Tecic Vuger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2018
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid TumorsJeremy Lewin, Jean-Charles Soria, Anastasios Stathis, et al.
Journal of the National Cancer Institute|August 5, 2020
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine TherapyMaria Alice Franzoi, Daniel Eiger, Lieveke Ameye, et al.
World Journal of Urology|January 13, 2026
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004)Georges Mjaess, Thierry Quackels, Jean-Christophe Fantoni, et al.
The Oncologist|April 20, 2016
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate CancerNeeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, et al.
Pageof 32

Showing results (231-240 of 311) with videos related to

Sort By:
Pageof 32
Oncotarget|December 2, 2016
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancerMarzia A Locatelli, Philippe Aftimos, E Claire Dees, et al.
Clinical Colorectal Cancer|July 8, 2020
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast CancerSilvia Camera, Amélie Deleporte, Giacomo Bregni, et al.
Anticancer Research|June 10, 2019
Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted TherapiesZiad El Ali, Sylvie Rottey, Philippe Barthelemy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2022
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket studyFederico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, et al.
Future Oncology (London, England)|May 9, 2025
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to accessJesús Garcia-Foncillas, Arnaud Bayle, Dirk Arnold, et al.
Journal of Cancer Research and Clinical Oncology|July 22, 2022
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysisDiogo Martins-Branco, Guilherme Nader-Marta, Ana Tecic Vuger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2018
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid TumorsJeremy Lewin, Jean-Charles Soria, Anastasios Stathis, et al.
Journal of the National Cancer Institute|August 5, 2020
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine TherapyMaria Alice Franzoi, Daniel Eiger, Lieveke Ameye, et al.
World Journal of Urology|January 13, 2026
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004)Georges Mjaess, Thierry Quackels, Jean-Christophe Fantoni, et al.
The Oncologist|April 20, 2016
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate CancerNeeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, et al.
Pageof 32